Survey Reveals Biotech Professionals' Attitude Toward New Business Models
A recent, free report, reveals biotech professionals' evaluations of potential business model alternatives for the future.
The following table shows the results of respondents' answers to the question: Given that some of the more traditional avenues to drug development could be facing problems, from the list below please indicate any change in your company’s stance or relative interest in using each drug development model/partner. As you will see from the following responses, choices varied greatly.
Source: Industry Standard Research, 2009.
You can view the full report
For more information on biotech, please see:
More Data Points:
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
Generative AI Transforms Clinical Study Report DevelopmentSeptember 16th 2025
Operational Strategies That Strengthened the NIMBLE Trial DesignSeptember 16th 2025
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
